High renewal and maintenance of multipotency of human adult stem cells (hSCs), are a prerequisite for experimental analysis as well as for potential clinical usages. The most widely used strategy for hSC culture and proliferation is using serum. However, serum is poorly defined and has a considerable degree of inter-batch variation, which makes it difficult for large-scale mesenchymal stem cells (MSCs) expansion in homogeneous culture conditions. Moreover, it is often observed that cells grown in serum-containing media spontaneously differentiate into unknown and/or undesired phenotypes. Another way of maintaining hSC development is using cytokines and/or tissue-specific growth factors; this is a very expensive approach and can lead to early unwanted differentiation. In order to circumvent these issues, we investigated the role of sphingosine-1-phosphate (S1P), in the growth and multipotency maintenance of human bone marrow and adipose tissue-derived MSCs. We show that S1P induces growth, and in combination with reduced serum, or with the growth factors FGF and platelet-derived growth factor-AB, S1P has an enhancing effect on growth. We also show that the MSCs cultured in S1P-supplemented media are able to maintain their differentiation potential for at least as long as that for cells grown in the usual serum-containing media. This is shown by the ability of cells grown in S1P-containing media to be able to undergo osteogenic as well as adipogenic differentiation. This is of interest, since S1P is a relatively inexpensive natural product, which can be obtained in homogeneous high-purity batches: this will minimize costs and potentially reduce the unwanted side effects observed with serum. Taken together, S1P is able to induce proliferation while maintaining the multipotency of different human stem cells, suggesting a potential for S1P in developing serum-free or serum-reduced defined medium for adult stem cell cultures.
Introduction
Adult mesenchymal stem cells (MSCs) have the ability to differentiate into several lineages of mesodermal tissues, including bone, cartilage, fat, skeletal muscle, and tendons, under appropriate culturing conditions using specific growth factors and/or hormones (Pittenger et al., 1999; Barry and Murphy, 2004; Le Blanc and Ringden, 2006) . MSCs have been isolated from fetal liver, umbilical cord blood and bone marrow (Wagner et al., 2005; Kern et al., 2006) . Very recently, adipose-tissue-derived stromal cells (ADSCs) (Zuk et al., 2002; Katz et al., 2005; Rodriguez et al., 2005) have been identified as having equal potential for differentiating into lineages of mesodermal origin, including adipocytes, bone, cartilage and skeletal muscle (Zuk et al., 2001; Dicker et al., 2005) .
Currently, the most widely used strategy for human MSC proliferation is using serum, which contains various growth factors that promote MSC proliferation. However, serum composition is poorly defined, which may affect MSCs in culture in an unknown way. Also, serum has a considerable degree of interbatch variation, which makes it difficult for large-scale MSC expansion in the same culture condition. Moreover, it is often observed that cells grown in serum-containing media spontaneously differentiate into unknown and/or undesired phenotypes. In order to circumvent these issues, serum-free or serum-reduced strategies using exogenous growth factors or cytokines are being developed. However, most growth factors and cytokines used are very expensive, which makes the large-scale expansion, under these conditions, very costly.
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Moreover, the full effects of cytokines and growth factor on stem cells are not fully understood. Therefore, it is still of value to develop cheaper, and defined, growth-inducing supplements, for serum-free or serum-reduced media for MSC self-renewal.
The bioactive lysophospholipid sphingosine-1-phosphate (S1P) has recently been shown to be involved in the proliferation of various cell types (Spiegel and Milstien, 2002) . So far, five-cell surface G-protein-coupled receptors termed S1P 1 , S1P 2 , S1P 3 , S1P 4 and S1P 5 , have been shown to mediate most biological actions of extracellular S1P (Spiegel and Milstien, 2002) . Recently, an elegant report by Pébay et al. (2005) demonstrated that S1P could induce embryonic stem cell proliferation. They showed that S1P worked synergistically with platelet-derived growth factor (PDGF) and had promising effects on human embryonic stem cell proliferation (Pébay et al., 2005) . However, whether these observations can be translated to human and/or adult stem cells remains to be elucidated. Thus, we decided to investigate the role of S1P in human adult stem cell (hSC) proliferation and differentiation.
In this study, we used human bone marrow-derived MSCs (BM-MSCs) and human adipose tissue-derived MSCs (AD-MSCs). Human BM-MSCs are widely used and developed in the area of tissue engineering research and in clinics, while human AD-MSCs are newly found and thus not fully characterized yet. Our study focused on the role of S1P on proliferation and multipotency maintenance of both human BM-MSCs and AD-MSCs. We show here that both cell types express all of the five known S1P receptors (S1P 1 , S1P 2 , S1P 3 , S1P 4 , S1P 5 ), although at different levels. Our results support a role for S1P in adult stem cell proliferation and contribute towards the generation of serum-free culture conditions that maintain the multipotency of the cells.
Results

S1P receptors expressed on BM-MSCs and AD-MSCs
So far the relative expression levels of the various S1P receptors on hSCs are not fully characterized. It has been reported that BM-MSCs express S1P 1 and S1P 2 (Pébay et al., 2007) , and that at the mRNA level human AD-MSCs express all five S1P receptors (Nincheri et al., 2009 ).
Here we report that all five S1P receptors are expressed in both human adult bone-marrow and adipose tissue-derived cells. These five receptors were measured for their mRNA and protein expression levels. In quantitative real-time PCR ( Figure 1A) , we show that human AD-MSCs and BM-MSCs expressed all five S1P receptors, with S1P 4 and S1P 5 expressed at lower levels ( Figure 1A ). Fluorescent microscopy of immunostained cells was used to detect the protein expression of S1P 1 , S1P 2 , S1P 3 , S1P 4 and S1P 5 in human AD-MSCs and BM-MSCs. The fluorescence microscopy cell images, shown in Figure 1B , indicate that both cell types express all of the five S1P-receptors ( Figure 1B) .
It should be remarked that the fluorescence density of each staining might not reflect the exact amount of protein expression of these receptors, as although the same amount and same dilution of the primary antibodies and the same secondary antibody were used for each sample, the efficiency of each primary antibody might not be the same. Therefore, we performed FACS analysis for all the receptors and 98 + 2% of the cells expressed all the receptors (data not shown). Thus, our data indicate that all the S1P receptors are expressed in human adult AD-MSCs and BM-MSCs.
Figure 1 S1P receptor expression in human adipose-derived and bone marrow MSCs. (A) One microgram of total RNA was used to investigate the relative mRNA expression levels of S1P 1 , S1P 2 , S1P 3 , S1P 4 and S1P 5 by quantitative real-time PCR: data shown from human bone marrow-derived MSCs (BM-MSCs), and from human adipose tissue-derived MSCs (AD-MSCs). Results shown are the mean +SD of triplicate measurements from at least three separate experiments. (B) Immunostaining of S1P 1 , S1P 2 , S1P 3 , S1P 4 and S1P 5 in BM-MSCs, and AD-MSCs. Green fluorescence represents FITC staining of the different S1P receptors tested, and blue fluorescence represents the location of the cell nucleus. Microscopy magnification is 200×. R e t r a c t e d S1P promoted BM-MSC and AD-MSC proliferation S1P promoted cell proliferation. Different doses of S1P (100, 500 nM and 1, 5 mM) were tested for their function in human BM-MSC and AD-MSC proliferation. Cells were cultured in serumfree Dulbeco's modified Eagle's medium (DMEM) supplemented only with different amounts of S1P. Cell growth was measured after 4 days, by detecting the total amount of DNA in different samples, and the results are shown in Figure 2 . Interestingly, it showed that a lower dose (≤1 mM) of S1P promoted BM-MSC ( Figure 2A ) and AD-MSC ( Figure 2B ) proliferation. However, at a higher dose of S1P (5 mM), cell growth was not observed. It has been shown that high amounts of S1P, or synthetic S1P-receptor agonists, can lead to growth arrest and apoptosis in different cell types. This has been shown to be driven by either S1P 3 or S1P 5 , depending on the cell system (Malek et al., 2001; Karliner, 2002; Tsukada et al., 2007; Landeen et al., 2008) . The S1P receptor signaling system is very complex, with five receptor subtypes, and evidence for receptor coexpression and promiscuous coupling allows variable and complex signals to be generated. In our study 5 mM of S1P caused cell death, it may be that the high dose of S1P caused adult stem cell death caused by pro-apoptotic signals triggered by the S1P receptors 3 and/or 5, as has been suggested for various cell types (Malek et al., 2001; Karliner, 2002; Tsukada et al., 2007; Landeen et al., 2008) : this is currently under investigation. S1P and serum promoted an enhanced cell proliferation. After detecting the role of S1P in AD-MSC and BM-MSC proliferation, S1P, together with either 10% fetal bovine serum (FBS) or 1% FBS, were tested for their role in proliferation. Cells were cultured in DMEM supplemented with either 10% FBS or 1% FBS, with different amounts of S1P, for 4 days, and cell proliferation was compared and summarized in Figure 3 . It was observed that S1P worked synergistically with 10% serum ( Figure 3A and B), but more importantly, also did so in reduced serum (1% FBS) ( Figure 3C and D) . Thus, the addition of S1P promoted a substantially higher cell growth rate than serum alone.
In an attempt to minimize the side effects of serum (i.e. spontaneous differentiation) (reviewed in Pébay et al., 2007; Schäffler and Büchler, 2007) , we combined two well-known growth factors with S1P, namely FGF2 and PDGF-AB. Thus, either FGF2 or PDGF-AB was combined with different amounts of S1P, and the cells were cultured for 4 days in different growth factors alone or in combination with S1P ( Figure 4 ). We show here that S1P alone induces a similar level of proliferation as that observed using 1 ng/ml of FGF2, or 20 ng/ml of PDGF-AB, for both BM-MSCs and AD-MSCs ( Figure 4A and B). Interestingly, in combination with either FGF or PDGF-AB, S1P had an additive effect in increasing the level of proliferation, and all these were added together (S1P, FGF and PDGF-AB), an even higher level of proliferation was observed ( Figure 4A and B). This latter combination of growth factors and S1P achieved a much higher level of proliferation than that achieved with the standard 10% FBS. Furthermore, analysis on cell morphology revealed that no significant changes were observed in cells grown under the different culture conditions ( Figure 4C ). Taken together, these data indicate that S1P could be a critical component for working together with other growth factors in developing serum-free stem cell expansion strategies.
S1P maintains multipotency of BM-MSCs and AD-MSCs
After identifying the function of S1P (S1P alone, S1P with serum, S1P with other growth factors) in human AD-MSC and BM-MSC proliferation, cells were then investigated for their multipotency. In order to further examine the function of S1P in maintaining stem cell multipotency, the following were measured in cells cultured with or without S1P: cell surface marker expression profile (Table 1) , osteogenic and adipogenic differentiation potential (Figures 5 and 6 ).
So far, there are no particular cell surface markers, which are expressed only in MSCs. However, it is agreed that if the expression of a known number of cell surface proteins typically found in stem cells remains the same after several passages, it implies that the stem cells have retained their multipotency. Thus, both human BM-MSCs and human AD-MSCs were cultured in standard serum-supplemented media as control, or cultured in 100 nM (100 nM S1P), 500 nM (500 nM S1P), 1 mM (1 mM S1P) and 5 mM (5 mM S1P). Results shown are the mean +SD of triplicate measurements from at least three separate experiments. Student t-test, *P, 0.05 and **P , 0.01, compared with the initial cell number (Day 0).
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serum-reduced media supplemented with S1P, analyzed by flow cytometry for expression of the various cell surface markers (stated in the methods) whenever they grew confluent, then processed to the next passage. The percentages of cells expressing the different markers are summarized in Table 1 . Interestingly, it was found that the expression of certain cell surface markers in the starting cell populations were lower than those from later passages ( Table 1 , human BM-MSCs: CD73 and CD105 in passage 6; Table 1 , human AD-MSCs-donor 1: CD105 in passage 4; Table 1 , human AD-MSCs-donor 2: CD29, CD73, CD90 and CD105 in passage 4). However, if cells from the same passage but different culture conditions (in 10% FBS or in 1 mM S1P + 1% FBS) were compared for receptor expression, there was no significant difference in cell surface marker expression.
Three typical differentiation pathways for MSCs are osteogenic, chondrogenic and adipogenic differentiation (Zuk et al., 2001 (Zuk et al., , 2002 Schutze et al., 2005; Vilquin and Rosset, 2006; Hayashi et al., 2008) . In this study, osteogenic and adipogenic differentiations were chosen for investigating whether human MSCs cultured in S1P-supplemented media still retained their multi-lineage differentiation potential. Thus, our data show that cells cultured under the different conditions including S1P are capable of osteogenic differentiating ( Figure 5) . Interestingly, although our results show that there were no major variations in the osteogenic capacity of cells grown under the different culture conditions, it was observed that AD-MSCs ( Figure 5B ) have a stronger and/or faster osteogenic differentiation potential as compared with human bone BM-MSCs ( Figure 5A ). Oil Red O staining is a well-established method for staining lipid droplets, which makes this method the gold standard for detecting adipogenic differentiation. We show here that human BM-and AD-MSCs grown in S1P-containing media were also able to undergo adipogenic differentiation ( Figure 6 ). Taking together, these results suggest that culture media containing S1P does not influence the multipotency of the cells.
Discussion
The role of S1P in human bone marrow and adipose-derived MSC proliferation was investigated in this paper. The effect of S1P alone, S1P with standard or reduced amount of serum, and S1P with other growth factors (FGF2 and PDGF-AB) was studied on adult human MSC proliferation. Thus, we showed that S1P could work alone or additively with standard or reduced amount of serum, or in combination with other growth factors, such as FGF2 and PDGF-AB, to promote human MSC proliferation. Moreover, the presence of S1P did not show any significant side effects and the cells maintained their morphology, marker expression profile and osteogenic and adipogenic differentiation potential, which agrees with recent studies on embryonic stem cells (Pébay et al., 2005) , on neuronal progenitors (Harada Figure 3 S1P -triggered human MSC proliferation in serum-containing media. (A) Human BM-MSCs were cultured 4 days in DMEM containing 10% FBS (10% FBS) as growth control, or DMEM containing 10% FBS, supplemented with different amounts of S1P (10% FBS, 100 nM S1P); (10% FBS, 500 nM S1P); (10% FBS, 1 mM S1P). (B) Human AD-MSCs were cultured 4 days in DMEM containing 10% FBS (10% FBS) as growth control, or DMEM containing 10% FBS, supplemented with different amounts of S1P (10% FBS, 100 nM S1P); (10% FBS, 500 nM S1P); (10% FBS, 1 mM S1P). (C) Human BM-MSCs were cultured 4 days in DMEM containing 1% FBS (1% FBS), or DMEM containing 1% FBS, supplemented with different amounts of S1P (1% FBS, 100 nM S1P); (1% FBS, 500 nM S1P); (1% FBS, 1 mM S1P). (D) Human AD-MSCs were cultured 4 days in DMEM containing 1% FBS (1% FBS), or DMEM containing 1% FBS, supplemented with different amounts of S1P (1% FBS, 100 nM S1P); (1% FBS, 500 nM S1P); (1%FBS, 1 mM S1P). Results shown are the mean +SD of triplicate measurements from at least three separate experiments. Student t-test, *P, 0.05 and **P , 0.01, compared with the initial cell number (Day 0).
R e t r a c t e d et al., 2004) and on mesoangioblasts (in proliferation function
; multipotency maintenance was not tested in this study) (Donati et al., 2007) . In contrast a recent study suggests that S1P can induce the differentiation of adipose tissue-derived MSCs towards smooth muscle cells (Nincheri et al., 2009) . There are clear discrepancies in the recent literature on the role of S1P in adult stem cell research, which warrant further investigations.
Taken together, our findings indicate that S1P could potentially be used as an additive, in developing serum-reduced or serumfree strategies for stem cell proliferation. The importance of these findings is highlighted by the indication that using S1P in stem cell expansion strategies would not only contribute to promoting cell growth, but may also lead to reducing the spontaneous differentiation observed in serum-rich culture conditions. supplemented with 10% FBS at day 0 (1); or cultured for 4 days in DMEM supplemented with: (2) 10% FBS; (3) 500 nM S1P; (4) 1 mM S1P; (5) 1 ng/ml FGF; (6) 20 ng/ml PDGF-AB; (7) 500 nM S1P + 1 ng/ml FGF; (8) 1 mM S1P + 1 ng/ml FGF; (9) 500 nM S1P + 20 ng/ml PDGF-AB; (10) 1 mM S1P + 20 ng/ml PDGF-AB; (11) 500 nM S1P + 1 ng/ml FGF + 20 ng/ml PDGF-AB; (12) 1 mM S1P + 1 ng/ml FGF + 20 ng/ml PDGF-AB. (B) Human AD-MSC cultured in DMEM supplemented with 10% FBS at day 0 (1); or cultured for 4 days in DMEM supplemented with: (2) 10% FBS; (3) 500 nM S1P; (4) 1 mM S1P; (5) 1 ng/ml FGF; (6) 20 ng/ml PDGF-AB; (7) 500 nM S1P + 1 ng/ml FGF; (8) 1 mM S1P + 1 ng/ml FGF; (9) 500 nM S1P + 20 ng/ml PDGF-AB; (10) 1 mM S1P + 20 ng/ml PDGF-AB; (11) 500 nM S1P + 1 ng/ml FGF + 20 ng/ml PDGF; (12) 1 mM S1P + 1 ng/ml FGF + 20 ng/ml PDGF-AB. Results shown are the mean +SD of triplicate measurements from at least three separate experiments. Student t-test, *P, 0.05 and **P , 0.01, compared with the initial cell number (Day 0). (C) Cell morphology of the cells in the various treatments the shape of non-confluent-treated cells in comparison to non-treated ones. Results shown are representative of at least three separate experiments.
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Materials and Methods
Materials
Unless otherwise stated, all chemicals were purchased from Sigma-Aldrich, Singapore.
Human stem cells
Human bone marrow MSCs (BM-MSCs) were purchased from Cambrex Corp. The cells were obtained from bone marrow withdrawn from the posterior iliac crest of pelvic bone of normal volunteers (healthy males and non-pregnant females between the ages of 18 and 45 years old). Human adipose tissue-derived mesenchymal cells (AD-MSCs) were obtained from healthy volunteers after written consent was obtained and following the guidelines for permission for the procurement of human adipose tissue from the Institutional Review Board, National University Hospital, Singapore. The adipose tissue was obtained from donors who underwent elective liposuction, after signed ethical consent and approval forms. Then, a modified cell isolation protocol, based on Zuk et al.'s (2001) method, was used to process the adipose tissues. Briefly, the tissues were first washed at least three times with phosphate-buffered saline solution (PBS) to remove the blood from the adipose tissues. Tissues were then digested with 0.075% collagenase Type I (Gibco no. 17101-015) for 2 h at 378C with occasional shaking. The mixture was then spun down at 300 g for 10 min. Cells were then plated on culture flasks (TPP, Trasadingen, Switzerland) . Once the cells were attached to the culture flask, the medium was changed to remove unattached cells.
Cell culture
Unless otherwise stated, cell seeding density was 5000 cells/ cm 2 . Both cell types were cultured in DMEM (Gibco, no. 10569), supplemented with 10% heat-inactivated FBS (Gibco), 1% of 2 mM L-glutamate, 10 mg/ml streptomycin and 10 U/ml penicillin. For some experiments, the FBS was reduced and the media were supplemented with S1P at different concentrations, as stated in the figures. The growth medium was changed every 3 days. Cells were cultured in an incubator at 378C, 5% CO 2 , in a humidified environment.
Quantitative real-time PCR
The quantitative real-time PCR used in this study followed the protocol developed by Leong et al. (2007) , for total mRNA quantification. In brief, real-time PCR was performed using 1 mg of total Table 1 Cell surface marker expression in human bone marrow-derived MSCs and human adipose tissue-derived MSCs.
Primary antibody
Percentage of total events P 5 6 P 5 7 P 5 8 P 5 9
Ctrl Ctrl S1P Ctrl S1P Ctrl S1P R e t r a c t e d Figure 5 Osteogenic differentiation potential of cells cultured under different conditions. Human BM-MSCs (A), or human AD-MSCs (B), were first cultured in: DMEM supplemented with 10% FBS (DMEM + 10% FBS); DMEM supplemented with 1% FBS (DMEM + 1% FBS); DMEM supplemented with 500 nM S1P (DMEM + 500 nM S1P) and DMEM supplemented with 500 nM S1P and 1% FBS (DMEM + 500 nM S1P + 1% FBS), for 12 days. An equal amount of cells from each culture condition were seeded in 48-well plates with normal culture medium, supplemented with (osteogenic-induced) or without (uninduced) osteogenic differentiation media for another 28 days. The cells were stained with Alizarin Red S, mineralization was visualized by microscopy (to panels/images), and quantified by detecting the absorbance at 500 nM (bottom panels/ histograms). Microscopy data shown are representative of triplicate samples or three separate experiments. Histogram results are the average +the standard deviation of triplicate samples from three separate experiments (*P, 0.01, Student's t-test comparing uninduced with induced cells).
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RNA from BM-MSCs and from AD-MSCs. Primers for genes of interest were designed according to their cDNA sequences from PubMed. The uniqueness of the suitable pairs chosen was checked by "blast" (http://www.ncbi.nlm.nih.gov/blast/). All primers were purchased from Research BioLab (Singapore). Primer: S1P 1 (FW: atcatgtcctgctgcaagtg; RV: aggaattgtccgatt tgctg); S1P 2 (FW: ccttcagcatcctccttctg; RV: agggaattcagggtgga gac); S1P 3 (FW: caagcagcagcaacaatagc; RV: tgaagtgctgcgttctt gtc); S1P 4 (FW: gtctttggctccaacctctg; RV: gctgcggaaggagtag atga); S1P 5 (FW: tcttcctgctgctgttgct; RV: gcgtgtagatgatgggg ttc).
Immunostaining and fluorescent microscopy
Stem cells were seeded in IWAKI eight chamber slides (BioGen no. 5732-008) and cultured overnight to allow proper cell adhesion. Cells were then washed twice with PBS, fixed in 3.7%
paraformaldehyde for 15 min and permeabilized in 0.1% Triton-PBS twice, with 2 min each time. Cells were then blocked in 1% bovine serum albumin (BSA) for half an hour, and then probed for the five S1P receptors, with the following primary polyclonal rabbit antibodies: anti-human S1P 1 (Exalpha no. X1093P); anti-human S1P 2 (Exalpha no. X1591P); anti-human S1P 3 (Exalpha no. X1590P); anti-human S1P 4 (Exalpha no. X1592P); and anti-human S1P 5 (Abcam no. ab13130). For all these, 1:100 dilution of antibody in 1% BSA was used to probe the cells separately. Cells were incubated with primary antibodies overnight at 48C, followed by two washes with PBS. Cells were then incubated with anti-rabbit IgG-FITC (Sigma no. F7512) for 2 h in the dark (1:100 dilution of antibody in 1% BSA). Cells were then washed twice with PBS and stained with nuclear stain Hoechst 33342 (1:2000 in 1× PBS) for 5 min. Cells were then washed twice with PBS. When cells were dry, one drop of Movoil mounting medium was added, before cells were covered by a coverslip. Edges of the glass coverslip were sealed with nail varnish and the image could be observed under fluorescence microscope.
Delivery of S1P to cells D-erythro-S1P was first dissolved in methanol at 658C, as its solubility in other solvents is very poor. The methanol was then evaporated by a stream of nitrogen. A thin lipid film was thus generated on the inside of the tube. The dried S1P was resuspended in PBS containing 0.1% fatty-acid-free BSA to make a uniform 10 mM S1P-BSA stock solution. This stock was then diluted with 0.1% fatty-acid-free BSA, to reach the experimental S1P concentrations stated in the figures.
Stem cell proliferation assay
To compare cell proliferation under different culture conditions, MSCs were seeded in 48-well plates in growth medium (DMEM + 10% FBS) first. After 24 h of incubation, cells were gently washed twice with warm (378C) PBS to remove serum in the culture medium. Fresh and warm (378C) DMEM was added into each well, supplemented with S1P, or serum, or other growth factors. Cells were cultured for an additional 4 days. At day 4, cells were washed twice with warm (378C) PBS. Cells were then lysed and the DNA components were measured by PicoGreen. PicoGreen is a fluorescence dye, which can bind to double-stranded DNA. The fluorescent intensity is in proportion to the amount of DNA: this is analyzed in relation to standard curves, reflecting the cell numbers.
Cell surface marker expression (flow cytometry)
Human BM-MSCs and human AD-MSCs were analyzed by flow cytometry for their expression of CD29, CD34, CD44, CD45, CD71, CD73, CD90 and CD105. Briefly, cells were removed from the culture, using 0.125% trypsin and washed once in maintenance media before counting. Cells were rested for 40 min in maintenance media. 1 × 10 5 cells were then aliquoted into a 96-well plate and centrifuged at 450 g for 5 min. Pre-diluted antibody solutions in 2% Fetal Calf Serum (FCS)/PBS were subsequently Figure 6 Adipogenic differentiation. Human BM-MSCs (A), or human AD-MSCs (B), were first cultured in: DMEM supplemented with 10% FBS (DMEM + 10% FBS); DMEM supplemented with 1% FBS (DMEM + 1% FBS); DMEM supplemented with 500 nM S1P (DMEM + 500 nM S1P); and DMEM supplemented with 500 nM S1P and 1% FBS (DMEM + 500 nM S1P + 1% FBS), for 12 days. Equal amount of cells from each culture condition were seeded in 48-well plates with normal culture medium, supplemented with (adipogenic-induced) or without (uninduced) adipogenic differentiation media for another 28 days. The cells were stained with Oil Red O, and stainings were quantified by detecting the absorbance at 500 nM. Results are the average +the standard deviation of triplicate samples from at least three separate experiments (*P, 0.01, **P , 0.05, Student's t-test).
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added to the cells and incubated on ice for 20 min, followed by two washes in 2% FCS/PBS, then resuspended in 100 ml of 4% PFA and incubated on ice for further 20 min. Cells were again washed twice in 2% FCS/PBS before resuspension in 200 ml of 2% FCS/PBS and analyzed in using an FACS Aria (BD Biosciences, USA). All samples were measured in triplicate for each cell line. Mouse IgG1 and IgG2a were used as isotype controls, to determine the positive cell populations (isotype cells ,5% positive cells). Five thousand events per antibody group were counted in triplicate samples.
Stem cell osteogenic induction culture
Stem cells were induced into osteogenic differentiation in growth medium (DMEM + 10% FBS + 1% Penicillin and Streptomycin), supplemented with 0.01 mM 1, 25-dihydroxyvitamin D3, 50 mM ascorbate-2-phosphate, 10 mM b-glycerophosphate. Cells were first seeded in a T25 culture flask overnight to allow for a proper cell adhesion. On the next day, cells were washed with PBS, and the media were changed according to the following growth conditions, DMEM supplemented with: 10% FBS; 1% FBS; 500 nM S1P; or 1% FBS + 500 nM S1P. Culture media were changed every 4 days and cells were cultured for 12 days. Cells were then trypsinized and re-seeded in 48-well plates and left to recover for 24 h before starting the different culture condition. Cells obtained from the same culture condition were separated into two groups: control (uninduced, cells cultured in normal growth medium); or induced (osteogenic induced, cells cultured in normal growth medium supplemented by osteogenic inducers), and triplicate samples were analyzed per group. Cells were cultured for a total of 28 days to allow for a thorough osteogenic differentiation to mature. Cells were then fixed and stained with Alizarin Red S to detect mineralization, a late stage marker for osteogenic differentiation.
Alizarin red S staining
Alizarin Red S staining is used to evaluate the calcium-rich deposits generated by cells in culture. The special staining was used to detect the mineralization in MSC osteogenic differentiation. Briefly, the induced cells were fixed in 10% formalin overnight at 48C. Alizarin Red S working solution was prepared by dissolving 2 g of Alizarin Red S powder (Sigma-Aldrich no. 05600) in 100 ml of distilled water. The pH of the working solution was adjusted to 4.1-4.3 using 0.5% ammonium. After discarding formalin and being washed twice by distilled water, Alizarin Red S working solution was added to fully cover the fixed cells. These were incubated at room temperature for 5 min then checked microscopically for the orange-red color indicative of mineralization. Excess dye was removed and the cells were washed three times with distilled water. Staining was visualized with an inverted Leica DM IRB microscope and recorded by a Leica DC 300F digital camera; pictures were analyzed with the Leica IM500 Image Manager software. Alizarin Red S staining in each sample was quantified by extracting the staining with diH 2 O and detecting the absorbance under 500 nm.
Oil red O staining
Oil Red O staining is used to evaluate the fat/adipose rich cells in culture. Oil Red O stock solution was prepared by dissolving 0.7 g of Oil Red O powder (Sigma-Aldrich no. O-0625) in 200 ml isopropanol, followed by filtration. A working solution was prepared by mixing six parts of the Oil Red O stock solution and four parts of distilled water. The cells were fixed in 10% formalin overnight at 48C. After the formalin was removed, samples were washed with 60% isopropanol, and Oil Red O working solution was added and incubated for 10 min at room temperature. The dye was removed and the cells were washed three times with distilled water. Oil Red O staining in each sample was quantified by dissolving the staining with 100% of isopropanol and detecting the absorbance at 500 nm.
Statistics
Student's t-test was used for statistical study, with P , 0.05 regarded as significant.
